Acrivon Therapeutics, Inc. (ACRV)
NASDAQ:ACRV
US Market
Holding ACRV?
Track your performance easily

Acrivon Therapeutics, Inc. (ACRV) Balance Sheet

159 Followers

Acrivon Therapeutics, Inc. Balance Sheet

Acrivon Therapeutics, Inc.'s total assets for Q2 2024 were $230.59M, an increase of 91.32% from the previous quarter. ACRV total liabilities were $14.53M for the fiscal quarter, a 15.83% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20
Total Assets
$ 138.26M$ 181.23M$ 106.59M$ 2.19M
Total Liabilities
$ 17.07M$ 10.75M$ 130.40M$ 10.60M
Total Equity Gross Minority
$ 121.19M$ 170.47M$ -23.81M$ -8.41M
Total Capitalization
$ 124.96M$ 174.71M$ -23.81M$ -8.41M
Preferred Stock Equity
----
Capital Lease Obligations
--$ 5.63M$ 0.00
Currency in USD

Acrivon Therapeutics, Inc. Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis